Results 301 to 310 of about 601,516 (329)
Some of the next articles are maybe not open access.
Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire +2 more sources
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire +2 more sources
New Biological Therapies for Low-Density Lipoprotein Cholesterol
Canadian Journal of Cardiology, 2023Depressed low-density lipoprotein cholesterol concentration protects against atherosclerotic cardiovascular disease. Natural hypocholesterolemia states can have a monogenic etiology, caused by pathogenic loss of function variants in the PCSK9, ANGPTL3, MTTP, or APOB genes.
Praneet K. Gill, Robert A. Hegele
openaire +2 more sources
Cyclosporine, Low-Density Lipoprotein, and Cholesterol
Mayo Clinic Proceedings, 1988Lipoproteins are known to be able to transport a variety of drugs. This report suggests that low-density lipoprotein not only functions as an important carrier of cyclosporine in plasma but also facilitates transport of cyclosporine across the cell membrane by means of the low-density lipoprotein receptor. Such a mechanism would explain (1) the similar
openaire +2 more sources
Low-Density Lipoprotein Cholesterol in Subclinical Hypothyroidism
Thyroid, 2000The significance of subclinical hypothyroidism in regard to ensuing hyperlipidemia remains unclear. Because an unfavorable lipid profile would provide a possible explanation for the reported association of coronary-heart disease with this syndrome, we have evaluated the relationship of thyrotropin (TSH) with total cholesterol, low-density-lipoprotein ...
H, Vierhapper +4 more
openaire +2 more sources
Reliability of Calculated Low-Density Lipoprotein Cholesterol
The American Journal of Cardiology, 2015Aggressive low-density lipoprotein cholesterol (LDL-C)-lowering strategies are recommended for prevention of cardiovascular events in high-risk populations. Guidelines recommend a 30% to 50% reduction in at-risk patients even when LDL-C concentrations are between 70 and 130 mg/dl (1.8 to 3.4 mmol/L).
Jeffrey W, Meeusen +4 more
openaire +2 more sources
International Journal of Cardiology, 2018
BACKGROUND Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels are established risk factors for cardiovascular diseases, a leading cause of death in China.
Mei Zhang +8 more
semanticscholar +1 more source
BACKGROUND Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels are established risk factors for cardiovascular diseases, a leading cause of death in China.
Mei Zhang +8 more
semanticscholar +1 more source
Hormone and Metabolic Research, 2001
The atherogenicity of triglyceride-rich lipoprotein has been revealed. This study was performed to explore the clinical importance of triglyceride-rich lipoprotein by measuring its cholesterol content and comparing it with other lipoprotein fractions. Blood samples were obtained from 103 patients whose fasting plasma triglyceride concentration exceeded
M, Ai +6 more
openaire +2 more sources
The atherogenicity of triglyceride-rich lipoprotein has been revealed. This study was performed to explore the clinical importance of triglyceride-rich lipoprotein by measuring its cholesterol content and comparing it with other lipoprotein fractions. Blood samples were obtained from 103 patients whose fasting plasma triglyceride concentration exceeded
M, Ai +6 more
openaire +2 more sources
Messqualität von „low density lipoprotein cholesterol“
Der Diabetologe, 2018Cholesterin als essenzieller Bestandteil von Biomembranen und Vorlaufer der Steroidsynthese wird ubiquitar im Korper benotigt. Aufgrund seiner Wasserunloslichkeit wird es im Blutplasma in Lipoproteinpartikeln transportiert, der Grosteil davon in LDL-Partikeln (LDL: „low density lipoprotein“).
A. Masuch +3 more
openaire +1 more source
Direct testing for low-density lipoprotein cholesterol
The American Journal of Cardiology, 19956. Ismen S. Olsen K, Jacohscn E. IGclscn H, S&en A. Pietensen A. Jensen 0. Pedenen I-‘, Waahcn J. Kehlet H. Hansen J. Dalgaard P. Nyboe J. Predictmu of cardiac risk in non-cardiac surgery. Lur f&w? J I9R7:8:179 18.5. 7. Ashmn C, Pewson Ii. Wray N, Kiefe C. Dunn J. Wu 1.. Thomas J.
openaire +2 more sources
New therapies to reduce low-density lipoprotein cholesterol
Current Opinion in Cardiology, 2013Lipid-lowering is an intervention that reduces atherosclerosis and its complications. Statins currently form the standard of care but are not able to reduce low-density lipoprotein cholesterol (LDL-C) adequately in all patients - particularly those with familial hypercholesterolaemia and those with statin intolerance.Combination therapy with statins is
Anthony S, Wierzbicki +3 more
openaire +2 more sources